Abstract
Although the coincidence of multiple sclerosis (MS) and central nervous system (CNS) tumors has been reported in over 30 cases in English literature, meningioma growth was associated with interferon-beta (INF-b) treated MS only in two of them. We report the case of a 19-year-old woman with clinically possible, laboratory supported MS, and a concomitant right intraventricular tumor with magnetic resonance imaging (MRI) characteristics consistent with meningioma (similar signal with grey matter on T1 and T2-weighted images and homogenous, intense enhancement). Two years after initiation of INF-b treatment, follow-up brain MRI revealed enlargement of the intraventricular mass and relative increase in the number of white matter lesions without significant clinical deterioration. She underwent almost total resection of the mass and histology confirmed the diagnosis of papillary meningioma. Based on the immunohistochemistry results, we speculate that INF-b resulted in meningioma growth by enhancing platelet derived growth factor (PDGF) receptors or/and down-regulating transforming growth factor receptors on the tumor itself.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bosch G (1912) Ein fall primarem Melanosarkom des Zentrlnervensystems bei multipler Sklerose. Zeit Med 33:917–922
Scully RE, Mark EJ, McNeely WF, Ebeling SH, Philips LD (1997) Weekly clinicopathological exercises. Case 12-1997. N Engl J Med 336:1163–1171
Moller H, Kneller RW, Boice JD, Olsen JH (1991) Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 84:214–220
Spaar FW, Wilkstrom J (1978) Multiple sclerosis and malignant neoplasm in central nervous system: a clinical and anatomical report of three cases. J Neurol 218:23–33
Salvi F, Mascalchi M, Plasmati R, Calbucci F, Pozzo GP, Tassinari CA (1992) Multiple lesions in cerebral white matter in two young adults with thoracic extramedullary tumors. J Neurol Neurosurg Psychiatry 55:216–219
Batay F, Al-Merfy O (2002) Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report in two cases. Acta Neurochir 144:365–368
Costa MF, Novis SA, Niemeyer PF, Pimentel ML, Novis RF, Duarte F (2000). Multiple sclerosis, spinal cord ependymoma and intracranial meningioma: case report [In Portuguese]. Arq Neuro-Psiquiatr 58:1133–1137
Lahl R (1980) Combination of multiple sclerosis and cerebral glioblastoma. Eur Neurol 19:192–197
Nahser HC, Vieregge P, Nau HE, Reinhardt V (1986) Coincidence of multiple sclerosis and glioma: clinical and radiological remarks on two cases. Surg Neurol 26:45–51
Khan OA, Bauserman SC, Rothman MI, Aldrich EF, Panitch HS (1997) Concurrence of multiple sclerosis and brain tumor: clinical considerations. Neurology 48:1330–1333
Kaba SE, De Monte F, Bruner JM, Kyritsis AP, Jaekle KI, Levin V, Yung A (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2b. Neurosurgery 40(2):271–275
Magrassi L, De Fraja C, Conti L, Butti G, Infuso L, Govoni S, Gattaneo E (1999) Expression of the JAK and STAT superfamilies in human meningiomas. J Neurosurg 91(3):440–446
Folkman J, Ingber D (1992) Inhibition of angiogenesis. Semin Cancer Biol 3:89–96
Yong VW (2002) Differential mechanisms of action of interferon-b and glatiramer acetate in MS. Neurology 59:802–808
Johnson MD, Woodard A, Kim P, Frexes-Steed M (2001) Evidence for mitogen-associated protein kinase activation and transduction of mitogen signals by platelet derived growth factor in human meningioma cells. J Neurosurg 94(2):293–300
Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P (2001) Platelet derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 49(6):776–785
Racke MK, Bonomo A, Scott DE (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Expert Med 180:1961–1966
Zhang ZJ, Muhr C, Wang JL (1996) Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells. Anticancer Res 16(2):1717–1723
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drevelegas, A., Xinou, E., Karacostas, D. et al. Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship?. Neuroradiology 47, 516–519 (2005). https://doi.org/10.1007/s00234-005-1392-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-005-1392-6